107 related articles for article (PubMed ID: 7594603)
1. IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines.
Burg M; Martin U; Rheinheimer C; Köhl J; Bautsch W; Böttger EC; Klos A
J Immunol; 1995 Nov; 155(9):4419-26. PubMed ID: 7594603
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines.
Burg M; Martin U; Bock D; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1996 Dec; 157(12):5574-81. PubMed ID: 8955209
[TBL] [Abstract][Full Text] [Related]
3. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
[TBL] [Abstract][Full Text] [Related]
4. Coupling of the C5a receptor to Gi in U-937 cells and in cells transfected with C5a receptor cDNA.
Vanek M; Hawkins LD; Gusovsky F
Mol Pharmacol; 1994 Nov; 46(5):832-9. PubMed ID: 7969069
[TBL] [Abstract][Full Text] [Related]
5. Chemoattractant receptors for interleukin-8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid.
Zahn S; Zwirner J; Spengler HP; Götze O
Eur J Immunol; 1997 Apr; 27(4):935-40. PubMed ID: 9130647
[TBL] [Abstract][Full Text] [Related]
6. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
[TBL] [Abstract][Full Text] [Related]
7. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
[TBL] [Abstract][Full Text] [Related]
8. Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells.
Wilmer WA; Kaumaya PT; Ember JA; Cosio FG
J Immunol; 1998 Jun; 160(11):5646-52. PubMed ID: 9605171
[TBL] [Abstract][Full Text] [Related]
9. C5a stimulus-secretion coupling in rat basophilic leukaemia (RBL-2H3) cells transfected with the human C5a receptor is mediated by pertussis and cholera toxin-sensitive G proteins.
Monk PN; Pease JE; Barker MD
Biochem Mol Biol Int; 1994 Jan; 32(1):13-20. PubMed ID: 8012277
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
11. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin.
Buchner RR; Hugli TE; Ember JA; Morgan EL
J Immunol; 1995 Jul; 155(1):308-15. PubMed ID: 7541417
[TBL] [Abstract][Full Text] [Related]
12. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
Tardif M; Mery L; Brouchon L; Boulay F
J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human phagocytic cell receptors for C5A and platelet activating factor expressed in Xenopus oocytes.
Murphy PM; Gallin EK; Tiffany HL
J Immunol; 1990 Oct; 145(7):2227-34. PubMed ID: 2168918
[TBL] [Abstract][Full Text] [Related]
14. C3a receptor on dibutyryl-cAMP-differentiated U937 cells and human neutrophils: the human C3a receptor characterized by functional responses and 125I-C3a binding.
Klos A; Bank S; Gietz C; Bautsch W; Köhl J; Burg M; Kretzschmar T
Biochemistry; 1992 Nov; 31(46):11274-82. PubMed ID: 1332754
[TBL] [Abstract][Full Text] [Related]
15. Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937.
Harris PE; Ralph P; Litcofsky P; Moore MA
Cancer Res; 1985 Jan; 45(1):9-13. PubMed ID: 2981161
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells.
Füreder W; Agis H; Willheim M; Bankl HC; Maier U; Kishi K; Müller MR; Czerwenka K; Radaszkiewicz T; Butterfield JH; Klappacher GW; Sperr WR; Oppermann M; Lechner K; Valent P
J Immunol; 1995 Sep; 155(6):3152-60. PubMed ID: 7673728
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic peptides against human anaphylatoxin C5a.
Kaneko Y; Okada N; Baranyi L; Azuma T; Okada H
Immunology; 1995 Sep; 86(1):149-54. PubMed ID: 7590876
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation, dephosphorylation, and recycling of the C5a receptor in differentiated HL60 cells.
Giannini E; Boulay F
J Immunol; 1995 Apr; 154(8):4055-64. PubMed ID: 7706744
[TBL] [Abstract][Full Text] [Related]
19. Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators.
Katona IM; Ohura K; Allen JB; Wahl LM; Chenoweth DE; Wahl SM
J Immunol; 1991 Jan; 146(2):708-14. PubMed ID: 1898961
[TBL] [Abstract][Full Text] [Related]
20. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung.
Haviland DL; McCoy RL; Whitehead WT; Akama H; Molmenti EP; Brown A; Haviland JC; Parks WC; Perlmutter DH; Wetsel RA
J Immunol; 1995 Feb; 154(4):1861-9. PubMed ID: 7836770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]